Compare MRDN & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRDN | QSI |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.1M | 165.6M |
| IPO Year | 2008 | 2020 |
| Metric | MRDN | QSI |
|---|---|---|
| Price | $10.96 | $1.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $19.73 | $2.30 |
| AVG Volume (30 Days) | 40.5K | ★ 8.4M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | ★ 0.35 | N/A |
| Revenue | ★ $182,863,373.00 | $2,436,000.00 |
| Revenue This Year | $12.08 | N/A |
| Revenue Next Year | $10.93 | $406.32 |
| P/E Ratio | $32.46 | ★ N/A |
| Revenue Growth | ★ 21.01 | N/A |
| 52 Week Low | $6.01 | $0.69 |
| 52 Week High | $16.09 | $2.73 |
| Indicator | MRDN | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 35.44 | 50.63 |
| Support Level | $10.68 | $0.81 |
| Resistance Level | $14.76 | $1.32 |
| Average True Range (ATR) | 0.57 | 0.19 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 16.47 | 36.42 |
Meridian Holdings Inc is engaged in the online gaming and betting business, providing sports betting, online casino, and gaming operations across multiple jurisdictions in Europe, Africa, and Central and South America. The company has three reportable segments: MeridianBet Group, GMAG, and RKings & CFAC. The MeridianBet Group segment includes retail and online sports betting, casinos, and related gaming operations. The GMAG segment focuses on the resale of third-party gaming content, mainly serving customers in the Asia-Pacific region. The RKings & CFAC segment is involved in pay-to-enter prize competitions and trade promotions conducted in the United Kingdom and Australia. It generates the majority of its revenue from the MeridianBet Group segment.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.